The epoch-making discoveries in the field of molecular diagnostics have remarkably enhanced the healthcare and life-science industry. This advancement has helped clinicians get a comprehensive analysis of the human genes to understand disorders and diseases and opt for the best treatment for patients. In this era of modern yet cost-effective next-generation molecular diagnostics techniques, , healthcare institutions around the world are seamlessly optimizing patient care, enhancing testing accuracy, and selecting appropriate and personalized medicine to treat infectious & genetic diseases, cancer, diabetes, and so forth.
Giving thoughts to the increasing demand for molecular diagnostic approaches especially after the onset of COVID 19, co-founders Divya Sriram & Sujoy Deb envisaged to set up a deep-tech & biotech startup-D-NOME, disrupting molecular diagnostics. A cancer molecular biologist and a genomics expert, the dynamic duo have combined their experiences in molecular diagnostics and Next-generation Sequencing to create a room-temperature LAMP technology. Their amalgamated passion and vision brought into being an innovative D-LAMP platform technology that is based on advanced molecular tools and synthetic biology. This endeavour is enabling advanced molecular diagnostics like RT-PCR & Genomics (NextGenSeq) to be affordable, scalable and accessible to all.
The company is virtually incubated at Center of Excellence – IoT & AI, Gurugram, which is a Joint initiative of the Ministry of Electronics & IT (MeitY), Govt. of Haryana, and NASSCOM.